What is your preferred mode of vascular access for testicular cancer regimens?

Actually, we try to avoid all vascular access devices, especially PORT, which causes a 10-20% risk for clot as well as infection. These are young healthy patients usually with excellent veins. Over 90% of our large patient populations with testis cancer simply get their 5 days of chemo with a restart for the IV daily.

See our recent editorial "Once Upon a Time" published in J Clinical Oncology Practice. We go through the scant data available comparing peripheral versus central access for first-line therapy of germ cell tumors. I can say with a fair amount of confidence in these young healthy men, that pretty much all high-volume centers utilize peripheral IVs only reserving central devices for only when it is absolutely necessary.

As someone who was at the forefront in the late 1980s of moving BEP from in-hospital to the outpatient setting, we had to adapt our strategies with existing technologies and skills. The standard became peripheral IVs placed by experienced oncology nurses who had pride and experience in starting and maintaining peripheral IVs. Fo...